http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12677931

Outgoing Links

Predicate Object
contentType Journal Article|Validation Study
endingPage 1596
issn 1078-0432
1557-3265
issueIdentifier 5
pageRange 1587-1596
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 1587
bibliographicCitation Stern HM, Padilla M, Wagner K, Amler L, Ashkenazi A. Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab. Clin Cancer Res. 2010 Mar 01;16(5):1587–96. doi: 10.1158/1078-0432.ccr-09-3108. PMID: 20179215.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_154a6ba99dd49f33fef248e5eb27f17b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6737e848009c794cd58e8374340905d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_240511214216263ef0ace93264af0b62
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b6652e1336cda62586994fb51b6ac89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d1d754268612eaf0b7c526acc7092e3
date 2010-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1078-0432.ccr-09-3108
https://pubmed.ncbi.nlm.nih.gov/20179215
isPartOf https://portal.issn.org/resource/ISSN/1557-3265
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1078-0432
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab
discusses http://id.nlm.nih.gov/mesh/M0439702
http://id.nlm.nih.gov/mesh/M0008877
http://id.nlm.nih.gov/mesh/M0072715
http://id.nlm.nih.gov/mesh/M0505296
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0026343
http://id.nlm.nih.gov/mesh/M0256022
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D007150Q000379
http://id.nlm.nih.gov/mesh/D053221Q000627
http://id.nlm.nih.gov/mesh/D005647Q000032
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D017350Q000032
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015179Q000188
http://id.nlm.nih.gov/mesh/D004797
http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D005647Q000096
http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D014408Q000096
http://id.nlm.nih.gov/mesh/D008175Q000378
http://id.nlm.nih.gov/mesh/D014408Q000032
http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D012680
http://id.nlm.nih.gov/mesh/D017350Q000096
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D002289Q000378
http://id.nlm.nih.gov/mesh/D015179Q000378
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_057f2386bb0d2f56aac3cfa6d26b7946
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_35524e3028af810ff9822ca2e181c9b0
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68245
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_009c2b08eed80b47ce67ed2dffa157fc
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3b4c0dce854074377280922856819e26
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6ef217bf612813f3f8aaa204ca6ad259
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7346fb93fb77978c2580b12d5735002c

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2525
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96FL9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2528
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79623

Total number of triples: 69.